Galectin 10 抗体 (AA 2-142) (Biotin)
-
- 抗原 See all Galectin 10 (CLC) 抗体
- Galectin 10 (CLC) (Charcot-Leyden Crystal Protein (CLC))
-
抗原表位
- AA 2-142
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This Galectin 10 antibody is conjugated to Biotin
-
应用范围
- Western Blotting (WB)
- 特异性
- Human CLC
- 纯化方法
- Affinity purified
- 免疫原
-
Recombinant CLC (Ser2-Arg142) expressed in E. coli.
Type of Immunogen: Recombinant protein - 亚型
- IgG
- Top Product
- Discover our top product CLC Primary Antibody
-
-
- 应用备注
-
Approved: WB (1:100 - 1:400)
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - 说明
-
Target Species of Antibody: Human
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- PBS, pH 7.4, 0.02 % sodium azide, 50 % glycerol.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C,-80 °C
- 储存方法
- Store frozen product at or below -20°C. Thawed product may be stored for 2-4 weeks at 4°C. For optimal storage, aliquot to smaller portions and store at -20°C to -70°C. Avoid freeze-thaw cycles.
-
- 抗原
- Galectin 10 (CLC) (Charcot-Leyden Crystal Protein (CLC))
- 别名
- CLC (CLC 产品)
- 别名
- GAL10 antibody, Gal-10 antibody, LGALS10 antibody, LGALS10A antibody, LPPL_HUMAN antibody, Clcp antibody, gal-10 antibody, Bsf3 antibody, CLC antibody, GAL 10 antibody, Gal-8 antibody, Gal8 antibody, Charcot-Leyden crystal galectin antibody, Charcot-Leyden crystal protein antibody, cardiotrophin-like cytokine factor 1 antibody, avian beta-defensin 10 antibody, CLC antibody, Clc antibody, Clcf1 antibody, AvBD10 antibody
- 背景
-
Name/Gene ID: CLC
Synonyms: CLC, Charcot-Leyden crystal protein, Eosinophil lysophospholipase, Gal-10, LGALS10A, LPPL_HUMAN, Galectin-10, GAL10, Galectin 10, LGALS10, Lysolecithin acylhydrolase - 基因ID
- 1178
- 途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
-